Compare EVOK & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVOK | VIVK |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 19.5M |
| IPO Year | 2013 | N/A |
| Metric | EVOK | VIVK |
|---|---|---|
| Price | $10.98 | $0.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.4K | ★ 25.6M |
| Earning Date | 11-13-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $14,424,652.00 | ★ $125,113,426.00 |
| Revenue This Year | $58.96 | N/A |
| Revenue Next Year | $57.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 67.40 | ★ 101.82 |
| 52 Week Low | $1.94 | $0.06 |
| 52 Week High | $10.99 | $1.49 |
| Indicator | EVOK | VIVK |
|---|---|---|
| Relative Strength Index (RSI) | 85.18 | 27.40 |
| Support Level | $10.66 | $0.06 |
| Resistance Level | $10.99 | $0.09 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | -0.18 | 0.00 |
| Stochastic Oscillator | 95.00 | 10.48 |
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.